Deferring treatment in hairy cell leukemia: is active surveillance safe?
Saved in:
| Main Authors: | Victoria M. Rogness, Xuefei Jia, Wei Wei, Brian T. Hill |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2025-11-01
|
| Series: | Blood Neoplasia |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S2950328025000743 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
«White spleen» in hairy cell leukemia
by: V. M. Milosavljević, et al.
Published: (2019-02-01) -
Hairy Cell Leukemia Masquerading as Pancytopenia in Pregnancy
by: Louisa Shackleton, et al.
Published: (2019-01-01) -
Experience of treatment of hairy cell leukemia with new drug Vero-cladribine
by: Yu. E. Ryabukhina, et al.
Published: (2022-11-01) -
Specificity of treatment is mandatory in very old patients with hairy cell leukemia
by: Marisavljević Dragomir, et al.
Published: (2015-01-01) -
Cell-binding microarray application in diagnosis of hairy cell leukemia
by: A. N. Khvastunova, et al.
Published: (2015-06-01)